Domain lumenal

IP3 Receptors. Figure 2 Key structural features of IP3 receptors. The key domains are shown in the central block. The upper structures show the suppressor domain (PDB accession code, 1XZZ) and the IBC (1N4K) with its (red) and p (blue) domains. A proposed structure for the pore region is shown below, with the selectivity filter shown in red only two of the four subunits are shown. The lowest panel shows reconstructed 3D structures of IP3R1 viewed (left to right) from ER lumen, the cytosol and in cross-section across the ER membrane (reproduced with permission from [4]). 

In addition to its role as the P-subunit of PHY, PDI acts independently by catalysing thiol/protein disulphide interchange. The role of PDI as the P-subunit in prolyl 4-hydroxylase is not related to its disulphide isomerase activity and experiments where the vertebrate PDI was mutated in both thioredoxin-like active domains had no effect on tetramer assembly (Vuori et al., 1992). PDI appears to function as a molecular chaperone, retaining the a-subunits in the correct catalytically active, non-aggregated form in the ER-lumen (John et al, 1993). Dissociation of the P-subunits results in insoluble aggregates of the a-subunits, analogous to a-subunits expressed in the absence of PDI. An additional function of PDI in the complex is to maintain the ER luminal location of the a-subunits, since deletion of the ER retention signal from PDI results in the secretion of the complex (Vuori et al., 1992). 

Vesicular proteins and lipids that are destined for the plasma membrane leave the TGN sorting station continuously. Incorporation into the plasma membrane is typically targeted to a particular membrane domain (dendrite, axon, presynaptic, postsynaptic membrane, etc.) but may or may not be triggered by extracellular stimuli. Exocytosis is the eukaryotic cellular process defined as the fusion of the vesicular membrane with the plasma membrane, leading to continuity between the intravesicular space and the extracellular space. Exocytosis carries out two main functions it provides membrane proteins and lipids from the vesicle membrane to the plasma membrane and releases the soluble contents of the lumen (proteins, peptides, etc.) to the extracellular milieu. Historically, exocytosis has been subdivided into constitutive and regulated (Fig. 9-6), where release of classical neurotransmitters at the synaptic terminal is a special case of regulated secretion [54]. 

The spike protein complex of the alphaviruses appears to be assembled in the ER. Cross-linking studies of Triton X-lOO-solubilized viral proteins have shown that the p62 and El proteins are linked together to form a complex in the ER (Ziemiecki et al.. 1980). The topology of these complexes is the reverse of that in the viral particle the spikes are within the lumen of the ER and the internal domain of E2 is on the cytoplasmic side of the ER membrane. 

During the cycle, large conformational changes take place within domains of the enzyme to make sure that calcium ions do not leak back into the cytoplasm but are occluded at binding sites within the SR membrane portion of the enzyme until such time that the enzyme s lumenal gate opens to release the ions to the lumen. 

Phosphoryl transfer to asp351 allows dissociation of ADP, and then the N and P domain interface opens. The A domain rotates so that the TGES loop closes into the gap left by the loss of ADP. The A domain rotation, in turn, causes marked rearrangement in transmembrane hehces, opening the lumenal gate and releasing Ca " ions into the lumen. 

The proximal tubular cell plays a major role in the elimination of both inorganic and organic substrates. The ceUs have two distinct membrane domains. The basolateral membrane is in contact with the blood, and the apical brush-border membrane lines the tubular lumen. 

A relatively small minority of APP molecules enter the p-secretase pathway in which p-secretase cleaves APP and releases a soluble fragment, sAPPp. The C-terminal membrane-bound C99 peptide is then cleaved by y-secretase within the transmembrane domain, and two major isoforms of 40 and 42 amino acid lengths with different C-termini, Ap40 and Ap42, are generated. Based on the amino acid sequence, p-secretase is predicted to be a type I transmembrane protein with the active site on the lumenal side of... 

The development of COX-2-specific inhibitors has been helped immensely by knowledge of the detailed three-dimensional structures of COX-1 and COX-2 (Fig. 1). Both proteins are homodimers. Each monomer (A/, 70,000) has an amphipathic domain that penetrates but does not span the ER this anchors the enzyme on the lumenal side of the ER (a very unusual topology—generally the hydrophobic regions of integral membrane proteins span the entire bilayer). Both catalytic sites are on the globular domain protruding into the ER lumen. 

---